BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17379167)

  • 1. Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery.
    Kommareddy S; Amiji M
    Nanomedicine; 2007 Mar; 3(1):32-42. PubMed ID: 17379167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione.
    Kommareddy S; Amiji M
    Bioconjug Chem; 2005; 16(6):1423-32. PubMed ID: 16287238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles.
    Kaul G; Amiji M
    J Pharm Sci; 2005 Jan; 94(1):184-98. PubMed ID: 15761942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.
    Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M
    J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice.
    Kommareddy S; Amiji M
    J Pharm Sci; 2007 Feb; 96(2):397-407. PubMed ID: 17075865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.
    Kaul G; Amiji M
    Pharm Res; 2005 Jun; 22(6):951-61. PubMed ID: 15948039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.
    Kaul G; Amiji M
    Pharm Res; 2002 Jul; 19(7):1061-7. PubMed ID: 12180540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors.
    Kommareddy S; Amiji M
    Cancer Gene Ther; 2007 May; 14(5):488-98. PubMed ID: 17363959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles.
    Xu J; Amiji M
    J Vis Exp; 2012 Jan; (59):e3612. PubMed ID: 22231028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered polyallylamine nanoparticles for efficient in vitro transfection.
    Pathak A; Aggarwal A; Kurupati RK; Patnaik S; Swami A; Singh Y; Kumar P; Vyas SP; Gupta KC
    Pharm Res; 2007 Aug; 24(8):1427-40. PubMed ID: 17385017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of poly(ethylene glycol)-introduced cationized gelatin as a non-viral gene carrier.
    Kushibiki T; Tabata Y
    J Biomater Sci Polym Ed; 2005; 16(11):1447-61. PubMed ID: 16370244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A thermo-sensitive NIPA-based co-polymer and monosize polycationic nanoparticle for non-viral gene transfer to smooth muscle cells.
    Laçin NT; Utkan GG; Kutsal T; Pişkin E
    J Biomater Sci Polym Ed; 2012; 23(5):577-92. PubMed ID: 21310109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery.
    Soto ER; Ostroff GR
    Bioconjug Chem; 2008 Apr; 19(4):840-8. PubMed ID: 18376856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression.
    Miyata K; Kakizawa Y; Nishiyama N; Harada A; Yamasaki Y; Koyama H; Kataoka K
    J Am Chem Soc; 2004 Mar; 126(8):2355-61. PubMed ID: 14982439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier.
    Choi YH; Liu F; Park JS; Kim SW
    Bioconjug Chem; 1998; 9(6):708-18. PubMed ID: 9815164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated guanidinylated polyallylamine as gene-delivery carrier.
    Chung YC; Wei MF; Chang FH; Young TH
    J Biomater Sci Polym Ed; 2011; 22(14):1829-43. PubMed ID: 20979687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery.
    Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z
    Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses.
    Madan J; Dhiman N; Sardana S; Aneja R; Chandra R; Katyal A
    Anticancer Drugs; 2011 Jul; 22(6):543-55. PubMed ID: 21471809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of plasmid IGF-1 to chondrocytes via cationized gelatin nanoparticles.
    Xu X; Capito RM; Spector M
    J Biomed Mater Res A; 2008 Jan; 84(1):73-83. PubMed ID: 17600330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.